The program provides financial support to the institutions of 3 junior faculty researchers for a 2-year period. Each award is funded up to USD130,000, to be paid in annual installments of up to USD65,000 per year for 2 years. Funding for the second year is contingent upon submission of a progress report by each junior faculty researcher and approval by the Chair of the Scientific Review Committee which oversees the program.
Recipients of these competitive awards under the program will be selected by a Committee (as defined below) comprised of independent academic leaders in the field of hematology/oncology (the “Scientific Review Committee” or the “Committee”). The Committee will review complete applications and select research proposals based on their scientific merit, feasibility, and innovation. Announcement of Award Recipients will be made at an awards dinner hosted by the Committee and senior representatives from Gilead.
Applicants must meet the eligibility criteria in order to be considered for an award.